The share of corresponding or leading authors in scientific publications on drug discovery in the UK is predicted to decline steadily from 80.75% in 2024 to 78.24% by 2028. Compared to the previous year, we observe a consistent year-on-year decrease, indicating a downward trend over these forecasted years.

Key Future Trends to Watch For:

Increased collaboration across international borders could dilute UK corresponding or leading author contributions.
The rise of multidisciplinary research teams may impact individual author prominence.
Ongoing innovations in AI and automation in research might shift publication dynamics, affecting authorship roles.